Interactive Transcript
0:04
So the first case we have today is gonna be the modality,
0:08
thyroid, um, cancer patient.
0:10
Uh, these, uh, the thyroid cancer, as you guys know,
0:13
is a neuroendocrine tumor
0:15
or neuro um, so neuro um, endocrine cells.
0:18
So, um, dotatate is um, um, usually done.
0:23
You can, we can also do F DG PET as well.
0:26
Um, so I wanted to show you um, example
0:29
of a Dotatate PET CT done for thyroid cancer patient.
0:32
And this is, as you see here,
0:35
as I we did see in prior sessions,
0:38
you have to adjust the intensity.
0:39
This is the map. You have to adjust the intensity to be able
0:42
to see these cancers.
0:45
When I'm up here, again, I'm not gonna go
0:46
through my search pattern, I'm gonna directly go
0:49
to the findings.
0:51
When I'm the neck, I'll increase the intensity
0:53
to look at the thyroid first.
0:56
Look at this, it's enlarged.
0:58
Um, nitrogenous in the CT here.
1:02
Thyroid usually is hyper dense because the odine content.
1:06
But look how there is a large infiltrative ill-defined mass
1:10
replacing most of the thyroid gland.
1:13
And this mass in most part is intensely uh, dotatate Avid
1:18
or SSA avid heterogeneously, intensely avid.
1:21
And there's extension outside of the thyroid.
1:23
Obviously you can see here how it's extending
1:26
outside the thyroid gland infiltrating aju structures.
1:31
That traia you can,
1:32
you can't see like really assuming you guys to see, um,
1:36
there's no uh, flings with the trachea esophagus here.
1:41
Very large infiltrated mass in the thyroid gland, right?
1:45
Aggressive mass here.
1:47
And there's of course some necrosis here,
1:49
which is photonic in the pet damage, right?
1:52
And then when you go up here, it's always,
1:54
there's the static, uh, left cervical lymph nodes,
1:58
multiple metastatic left cervical lymph nodes,
2:00
obviously lymphatic SCA lymph nodes.
2:03
Right? Now of course you,
2:07
we will describe it in the report location, like
2:10
what are the levels of metastatic lymph nodes.
2:14
Um, and then, and be careful
2:17
because of course you know the parotid plant is the
2:19
physiologic side for the dotatate.
2:23
So don't confuse that with metastatic disease, right?
2:26
And um,
2:30
just like looking here in the mastoid here,
2:32
there is some activity in the mastoid.
2:33
Let me see here, what's going on.
2:46
This like something in the mastoid
2:47
or something in the rain.
2:51
Just took me a second. Dunno if we did notice that.
2:56
It's very subtle, very mild activity. Sometimes it's
2:59
Also the, the sinuses, the venous sinuses.
3:04
Let's see on the map,
3:10
see there's little, some ality here and I can go back
3:13
and look at the case and see if we saw something
3:16
and if the patient has correlative images
3:18
that showed something there.
3:20
In this here
3:27
there's a little bit widening.
3:29
Yeah, I don't think we recommended in that, right?
3:40
Yeah, I'll look at that and maybe follow up if you
3:43
send you a follow-up email.
3:49
Subtle like focal activity here, again,
3:52
you don't see it till you
3:53
really increase the intensity high.
3:55
If you look at the regular like intensity,
3:57
it's like it'll skip through and it, it might be nothing.
4:00
It's really the level of activity is um, blood pool level.
4:04
So it might be nothing, it's not metastatic or anything.
4:07
And if it's anything it's gonna be like maybe um, mening
4:10
or most probably a
4:13
mening if anything.
4:16
Or one of these like benign
4:20
lesions in the brain if something.
4:22
Or at most it's gonna be maybe inflammation.
4:26
I don't see evidence of mastitis right now
4:29
but I have to investigate it more.
4:35
I'll look at that and I will give you a follow up guys.
4:38
So let's go back to our case.
4:42
So there is here, like we said, primary thyroid,
4:45
me thyroid cancer with metastatic cervical lymph nodes.
4:49
And then um, when I go down
4:56
there was I think nothing in the lungs, not SS a avid
5:01
or even non um, S ss a avid
5:06
and you have to adjust the intensity when you go down here
5:09
into the liver to be able
5:10
to see like real any liver static lesions.
5:14
Lemme change the intensity here
5:19
and don't forget also to decrease the intensity
5:21
to look at the spleen nicely.
5:23
'cause when it's really very intense,
5:25
you can't see really anything in the spleen.
5:28
There's nothing in the spleen. The kidneys are fine.
5:31
Then we go back to the tendency to look forward
5:34
to the neo lymph nodes and there is nothing, right?
5:38
So looking at the MIP again, what
5:43
you can see is the medullary thyroid
5:47
can infiltrated, sorry,
5:49
the infiltrated moderate thyroid cancer
5:52
and metastatic lymph nodes that you can
5:56
See in this. So
5:57
regional lymph nodes and primary thyroid cancer.
6:01
Uh, that's all you can see in this patient.
6:03
And there was no, um, bone mets.
6:11
So keep in mind that modality,
6:12
thyroid cancer is a neuroendocrine in the
6:14
neuroendocrine tumor categories.
6:16
And um, dotatate is very valuable
6:19
and, um, helpful in this patient,
6:22
these patient population, right?
6:25
There's reactive inflammatory lymph
6:27
nodes in the inguinal region.
6:30
There's nothing here too. This is degenerative.
6:33
And as you know, um, we know that also what some, one
6:37
of the pitfalls of dotatate is that the same as a bg.
6:42
See here there's some activity, mild activity
6:45
because, um, osteoblastic,
6:49
so breast receptor receptors.
6:51
So when there's some active, uh, changes for example
6:55
or healing fractures, they will show some to the activity,
6:59
don't get confused
7:01
and think that there's something going on.
7:02
This is just when it's obviously degenerative changes,
7:05
it's ion, there's no problem with that.
7:07
And activity is usually mild, can be moderate,
7:10
not more than that, right?
7:12
So that is it for this patient. There's nothing extra.